Epiminder Limited (ASX: EPI)
Sector: Health Care
Market cap: A$57M (as of 2 Nov 2026)
Epiminder is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Epiminder's groundbreaking Minder system is a sub-scalp device for continuous monitoring of electrographic brain activity an
Data as of 2 Nov 2026.
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 1 Dec 2025 | Cochlear Investments Pty Ltd and its associates named in section 6 of this notice | Entry | ?% → 50.900% | Filing ↗ |
| 1 Dec 2025 | Epiminder Limited | Entry | ?% → 47.800% | Filing ↗ |
| 1 Dec 2025 | The Bionics Institute of Australia | Entry | ?% → 7.300% | Filing ↗ |
| 27 Nov 2025 | COCHLEAR INVESTMENTS PTY LTD | Entry | ?% → 35.991% | Filing ↗ |
Director trades — on-market
Cash and runway
Ask about EPI in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has EPI raised money in the last year, and at what discount?
- What was EPI's latest cash position and runway?
Loading EPI…